{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:18:32Z","timestamp":1767705512940,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11060-018-2852-2","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T11:11:17Z","timestamp":1524136277000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis"],"prefix":"10.1007","volume":"139","author":[{"given":"Hidemitsu","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-8700","authenticated-orcid":false,"given":"Satoru","family":"Sasagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"issue":"1","key":"2852_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11060-004-8101-x","volume":"75","author":"S Taillibert","year":"2005","unstructured":"Taillibert S, Laigle-Donadey F, Chodkiewicz C, Sanson M, Hoang-Xuan K, Delattre J-Y (2005) Leptomeningeal metastases from solid malignancy: a review. J Neurooncol 75(1):85\u201399. \n                    https:\/\/doi.org\/10.1007\/s11060-004-8101-x","journal-title":"J Neurooncol"},{"issue":"1","key":"2852_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/107327481702400104","volume":"24","author":"E Rhun Le","year":"2017","unstructured":"Le Rhun E, Taillibert S, Chamberlain MC (2017) Neoplastic meningitis due to lung, breast, and melanoma metastases. Cancer Control 24(1):22\u201332","journal-title":"Cancer Control"},{"issue":"6","key":"2852_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/01.cco.0000245323.19411.d7","volume":"18","author":"S Taillibert","year":"2006","unstructured":"Taillibert S, Hildebrand J (2006) Treatment of central nervous system metastases: parenchymal, epidural, and leptomeningeal. Curr Opin Oncol 18(6):637\u2013643. \n                    https:\/\/doi.org\/10.1097\/01.cco.0000245323.19411.d7","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"2852_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00172949","volume":"13","author":"H Nakagawa","year":"1992","unstructured":"Nakagawa H, Murasawa A, Kubo S et al (1992) Diagnosis and treatment of patients with meningeal carcinomatosis. J Neurooncol 13(1):81\u201389","journal-title":"J Neurooncol"},{"issue":"2","key":"2852_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-011-0686-2","volume":"106","author":"J Grewal","year":"2012","unstructured":"Grewal J, Saria MG, Kesari S (2012) Novel approaches to treating leptomeningeal metastases. J Neurooncol 106(2):225\u2013234. \n                    https:\/\/doi.org\/10.1007\/s11060-011-0686-2","journal-title":"J Neurooncol"},{"issue":"3","key":"2852_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/archneurol.2010.18","volume":"67","author":"MD Groves","year":"2010","unstructured":"Groves MD (2010) New strategies in the management of leptomeningeal metastases. Arch Neurol 67(3):305\u2013312. \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.18","journal-title":"Arch Neurol"},{"issue":"2","key":"2852_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3978\/j.issn.2304-3865.2015.05.02","volume":"4","author":"P Roth","year":"2015","unstructured":"Roth P, Weller M (2015) Management of neoplastic meningitis. Chin Clin Oncol 4(2):26. \n                    https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2015.05.02","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"2852_CR8","first-page":"155","volume":"4","author":"MM Fields","year":"2013","unstructured":"Fields MM (2013) How to recognize and treat neoplastic meningitis. J Adv Pract Oncol 4(3):155\u2013160","journal-title":"J Adv Pract Oncol"},{"issue":"7","key":"2852_CR9","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1200\/JCO.2005.06.053","volume":"23","author":"SM Blaney","year":"2005","unstructured":"Blaney SM, Balis FM, Berg S et al (2005) Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol 23(7):1555\u20131563. \n                    https:\/\/doi.org\/10.1200\/JCO.2005.06.053","journal-title":"J Clin Oncol"},{"issue":"1","key":"2852_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1200\/JCO.2003.04.053","volume":"21","author":"SM Blaney","year":"2003","unstructured":"Blaney SM, Heideman R, Berg S et al (2003) Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol 21(1):143\u2013147. \n                    https:\/\/doi.org\/10.1200\/JCO.2003.04.053","journal-title":"J Clin Oncol"},{"issue":"5","key":"2852_CR11","first-page":"1183","volume":"5","author":"JH Sampson","year":"1999","unstructured":"Sampson JH, Archer GE, Villavicencio AT et al (1999) Treatment of neoplastic meningitis with intrathecal temozolomide. Clin Cancer Res 5(5):1183\u20131188","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2852_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1227\/01.NEU.0000166543.45294.F6","volume":"57","author":"H Nakagawa","year":"2005","unstructured":"Nakagawa H, Miyahara E, Suzuki T, Wada K, Tamura M, Fukushima Y (2005) Continuous intrathecal administration of 5-fluoro-2\u2032-deoxyuridine for the treatment of neoplastic meningitis. Neurosurgery 57(2):266\u2013280","journal-title":"Neurosurgery"},{"issue":"8","key":"2852_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/1541-7786.MCR-05-0002","volume":"3","author":"H Nakagawa","year":"2005","unstructured":"Nakagawa H, Yoshioka K, Miyahara E, Fukushima Y, Tamura M, Itoh K (2005) Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis. Mol Cancer Res 3(8):425\u2013433. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-05-0002","journal-title":"Mol Cancer Res"},{"issue":"2","key":"2852_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1574-6968.2002.tb11467.x","volume":"217","author":"SE Pryde","year":"2002","unstructured":"Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217(2):133\u2013139","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"2852_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mrrev.2009.04.001","volume":"682","author":"D Scharlau","year":"2009","unstructured":"Scharlau D, Borowicki A, Habermann N et al (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 682(1):39\u201353. \n                    https:\/\/doi.org\/10.1016\/j.mrrev.2009.04.001","journal-title":"Mutat Res"},{"issue":"3","key":"2852_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10555-015-9578-9","volume":"34","author":"JC Encarna\u00e7\u00e3o","year":"2015","unstructured":"Encarna\u00e7\u00e3o JC, Abrantes AM, Pires AS, Botelho MF (2015) Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Cancer Metastasis Rev 34(3):465\u2013478. \n                    https:\/\/doi.org\/10.1007\/s10555-015-9578-9","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"2852_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","volume":"27","author":"HM Hamer","year":"2007","unstructured":"Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer R-J (2007) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27(2):104\u2013119. \n                    https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03562.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"7 Suppl","key":"2852_CR18","doi-asserted-by":"publisher","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485S","volume":"133","author":"JR Davie","year":"2003","unstructured":"Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133(7 Suppl):2485S\u20132493S","journal-title":"J Nutr"},{"issue":"1","key":"2852_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21873\/anticanres.11286","volume":"37","author":"C Damaskos","year":"2017","unstructured":"Damaskos C, Valsami S, Kontos M et al (2017) Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer. Anticancer Res 37(1):35\u201346. \n                    https:\/\/doi.org\/10.21873\/anticanres.11286","journal-title":"Anticancer Res"},{"issue":"1","key":"2852_CR20","doi-asserted-by":"publisher","first-page":"e0147218","DOI":"10.1371\/journal.pone.0147218","volume":"11","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yi M, Zha L et al (2016) Sodium butyrate induces endoplasmic reticulum stress and autophagy in colorectal cells: implications for apoptosis. PLoS ONE 11(1):e0147218. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147218","journal-title":"PLoS ONE"},{"issue":"6","key":"2852_CR21","first-page":"1213","volume":"17","author":"I Hara","year":"2000","unstructured":"Hara I, Miyake H, Hara S, Arakawa S, Kamidono S (2000) Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int J Oncol 17(6):1213\u20131218","journal-title":"Int J Oncol"},{"issue":"10","key":"2852_CR22","first-page":"5429","volume":"34","author":"E-M Katzenmaier","year":"2014","unstructured":"Katzenmaier E-M, Andr\u00e9 S, Kopitz J, Gabius H-J (2014) Impact of sodium butyrate on the network of adhesion\/growth-regulatory galectins in human colon cancer in vitro. Anticancer Res 34(10):5429\u20135438","journal-title":"Anticancer Res"},{"issue":"7","key":"2852_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s11605-003-0031-y","volume":"7","author":"B Farrow","year":"2003","unstructured":"Farrow B, Rychahou P, O\u2019Connor KL, Evers BM (2003) Butyrate inhibits pancreatic cancer invasion. J Gastrointest Surg 7(7):864\u2013870","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"2852_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0304-3835(00)00676-5","volume":"163","author":"K Demary","year":"2001","unstructured":"Demary K, Wong L, Spanjaard RA (2001) Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells. Cancer Lett 163(1):103\u2013107","journal-title":"Cancer Lett"},{"issue":"3","key":"2852_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/00006123-200103000-00035","volume":"48","author":"HH Engelhard","year":"2001","unstructured":"Engelhard HH, Duncan HA, Kim S, Criswell PS, Van Eldik L (2001) Therapeutic effects of sodium butyrate on glioma cells in vitro and in the rat C6 glioma model. Neurosurgery 48(3):616\u2013625","journal-title":"Neurosurgery"},{"issue":"11","key":"2852_CR26","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0959-8049(98)00234-2","volume":"34","author":"RM Conway","year":"1998","unstructured":"Conway RM, Madigan MC, Billson FA, Penfold PL (1998) Vincristine- and cisplatin-induced apoptosis in human retinoblastoma. Potentiation by sodium butyrate. Eur J Cancer 34(11):1741\u20131748","journal-title":"Eur J Cancer"},{"issue":"6","key":"2852_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000030139","volume":"21","author":"M Lauricella","year":"2000","unstructured":"Lauricella M, Calvaruso G, Giuliano M et al (2000) Synergistic cytotoxic interactions between sodium butyrate, MG132 and camptothecin in human retinoblastoma Y79 cells. Tumour Biol 21(6):337\u2013348. doi:30139","journal-title":"Tumour Biol"},{"issue":"2\u20133","key":"2852_CR28","first-page":"267","volume":"56","author":"K Sankaranarayanan","year":"2000","unstructured":"Sankaranarayanan K, von Duyn A, Loos MJ, Meschini R, Natarajan AT (2000) Effects of sodium butyrate on X-ray and bleomycin-induced chromosome aberrations in human peripheral blood lymphocytes. Genet Res 56(2\u20133):267\u2013276","journal-title":"Genet Res"},{"issue":"11","key":"2852_CR29","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1080\/09553000050176243","volume":"76","author":"L Stoilov","year":"2000","unstructured":"Stoilov L, Darroudi F, Meschini R, van der Schans G, Mullenders LH, Natarajan AT (2000) Inhibition of repair of X-ray-induced DNA double-strand breaks in human lymphocytes exposed to sodium butyrate. Int J Radiat Biol 76(11):1485\u20131491","journal-title":"Int J Radiat Biol"},{"issue":"9237","key":"2852_CR30","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/S0140-6736(00)02787-2","volume":"356","author":"P Vernia","year":"2000","unstructured":"Vernia P, Fracasso PL, Casale V et al (2000) Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet 356(9237):1232\u20131235","journal-title":"Lancet"},{"issue":"3","key":"2852_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijrobp.2014.03.018","volume":"89","author":"A Maggio","year":"2014","unstructured":"Maggio A, Magli A, Rancati T et al (2014) Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study. Int J Radiat Oncol Biol Phys 89(3):518\u2013524. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2014.03.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2852_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00384-013-1807-5","volume":"29","author":"L Krokowicz","year":"2014","unstructured":"Krokowicz L, Stojcev Z, Kaczmarek BF et al (2014) Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis\u2014a prospective randomized study. Int J Colorectal Dis 29(3):387\u2013393. \n                    https:\/\/doi.org\/10.1007\/s00384-013-1807-5","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"2852_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2334-12-111","volume":"12","author":"R Raqib","year":"2012","unstructured":"Raqib R, Sarker P, Mily A et al (2012) Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. BMC Infect Dis 12(1):111. \n                    https:\/\/doi.org\/10.1186\/1471-2334-12-111","journal-title":"BMC Infect Dis"},{"key":"2852_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0049-2","author":"M Ziemka-Nalecz","year":"2016","unstructured":"Ziemka-Nalecz M, Jaworska J, Sypecka J, Polowy R, Filipkowski RK, Zalewska T (2016) Sodium butyrate, a histone deacetylase inhibitor, exhibits neuroprotective\/neurogenic effects in a rat model of neonatal hypoxia-ischemia. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-016-0049-2","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2852_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-017-0807-8","volume":"14","author":"J Jaworska","year":"2017","unstructured":"Jaworska J, Ziemka-Nalecz M, Sypecka J, Zalewska T (2017) The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia. J Neuroinflammation 14(1):34. \n                    https:\/\/doi.org\/10.1186\/s12974-017-0807-8","journal-title":"J Neuroinflammation"},{"key":"2852_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2016.03.031","volume":"1642","author":"H Li","year":"2016","unstructured":"Li H, Sun J, Wang F et al (2016) Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice. Brain Res 1642:70\u201378. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2016.03.031","journal-title":"Brain Res"},{"issue":"4","key":"2852_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0168-0102(89)90030-8","volume":"6","author":"H Asou","year":"1989","unstructured":"Asou H, Hirano S, Kohsaka S (1989) Changes in ganglioside composition and morphological features during the development of cultured astrocytes from rat brain. Neurosci Res 6(4):369\u2013375","journal-title":"Neurosci Res"},{"issue":"4","key":"2852_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ (2012) The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 48(4):612\u2013626. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2012.08.033","journal-title":"Mol Cell"},{"issue":"5930","key":"2852_CR39","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033. \n                    https:\/\/doi.org\/10.1126\/science.1160809","journal-title":"Science"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-2852-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2852-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2852-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T20:42:18Z","timestamp":1554583338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-2852-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2852"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-2852-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"assertion":[{"value":"4 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}